Investor Award Panel

3i

3i is a world leader in private equity and venture capital with focus on Buyouts, Growth Capital, Venture Capital and Infrastructure. The total 3i funds under management amounted to €10.4 Billion in September 2006. Each year 3i invests more than €2.7 Billion supporting people who start, grow, change and buy businesses. Total capital invested in the Nordic region is €800 Million.

Advent Venture Partners

One of the most experienced technology venture capital firms in the UK. Advent invests in both the Information and Communications Technology and Life Sciences sectors and today has over £500 million under management from institutional investors across Europe and the USA.

Atlas Venture

Atlas invest in technology and life sciences businesses and work to apply their operational and venture capital experience to help early-stage companies become successful, high-growth global businesses. Atlas has helped build over 300 companies in more than 16 different countries and is currently investing from its seventh fund and manages over $2 billion in capital.

Ipso Ventures

Ipso Ventures is a creator of sustainable technology and life science businesses. It does this through establishing partnerships with universities and other research institutions which own commercialisable Intellectual Property and by providing seed capital and other services including: The recruitment of experienced management; Business development consultancy; Corporate finance; Merger and acquisition advice and Strategic advice.
Ipso Ventures was admitted to AIM on 7th March 2007

MVM Life Science Partners

MVM Life Science Partners Ltd is a dedicated life science fund with offices in London, and Boston. MVM currently has $300 Million under management and MVM recently announced the first closure of their third fund of additionally $130 Million. MVM focuses in particular on early stage investments and is lead investor in about 60 percent of the investments. About 50 percent of these are placed in the US and the remaining part in Europe and mainly in the UK. MVM has so far only done one investment in Scandinavia

NBGI Ventures

NBGI Ventures currently manages a €60 million venture capital fund and is in the process of raising its second fund of similar size. NBGI Ventures has offices in London and Athens and considers investments across Europe focusing on early stage investments in technology and particularly in medtech. The Fund's typical investment size ranges between €2-5 million for a first investment.